Dr Erik Goluboff: A Career Dedicated to Improving Patient Outcomes

Dr Erik Goluboff is a highly respected medical professional in the field of urology and the Principal Medical Lead of Genentech’s drug development program in urologic cancers. With a big career, Dr Erik Goluboffhas held high positions at important organizations. He has earned great respect among his peers.
Dr Erik Goluboff has published several papers and articles on urologic cancers throughout his career. He has also served on the editorial board of numerous journals and publications and is an active member of numerous professional societies and organizations.
Dr Erik Goluboff’s commitment to the field of urologic cancers is unparalleled. He has dedicated his career to understanding, treating, and finding new treatments for urologic cancers, and his work has profoundly impacted countless patients’ lives. His expertise and experience make him a valuable asset to Genentech, as well as the medical field as a whole.
Dr Erik Goluboff received his Bachelor of Science degree in biology at the University of Maryland, followed by a Master of Science degree in Biomedical Science at the Johns Hopkins University School of Medicine. After completing his master’s degree, Dr Erik Goluboff attended Harvard Medical School and graduated with his Medical Degree in 1988. After completing his medical degree, Dr Erik Goluboff specialized in urology at the University of California San Francisco Medical Center.
Dr Erik Goluboff began his career in urology at the University of California San Francisco Medical Center, where he served as the Chief of Urology at the San Francisco General Hospital. After spending two years in this role, Dr Erik Goluboff joined the staff at Memorial Sloan-Kettering Cancer Center in New York City as the Chief of Urologic Oncology. At Memorial Sloan-Kettering, Dr Erik Goluboff was responsible for the development and implementation of new treatments for prostate and bladder cancer. While at Memorial Sloan Kettering, Dr Erik Goluboff also served as a professor in the Department of Urology at New York University School of Medicine.